Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 16

1.

Oligomannose-coated liposomes as a therapeutic antigen-delivery and an adjuvant vehicle for induction of in vivo tumor immunity.

Kojima N, Biao L, Nakayama T, Ishii M, Ikehara Y, Tsujimura K.

J Control Release. 2008 Jul 2;129(1):26-32. doi: 10.1016/j.jconrel.2008.03.023. Epub 2008 Apr 7.

PMID:
18485512
[PubMed - indexed for MEDLINE]
2.

Oligomannose-coated liposome as a novel adjuvant for the induction of cellular immune responses to control disease status.

Kojima N, Ishii M, Kawauchi Y, Takagi H.

Biomed Res Int. 2013;2013:562924. doi: 10.1155/2013/562924. Epub 2013 Oct 10. Review.

PMID:
24224170
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Clinical application of surface-linked liposomal antigens.

Uchida T, Taneichi M.

Mini Rev Med Chem. 2008 Feb;8(2):184-92. Review.

PMID:
18289102
[PubMed - indexed for MEDLINE]
4.

CpG oligonucleotide as an adjuvant for the treatment of prostate cancer.

Lubaroff DM, Karan D.

Adv Drug Deliv Rev. 2009 Mar 28;61(3):268-74. doi: 10.1016/j.addr.2008.12.005. Epub 2009 Jan 7. Review.

PMID:
19166887
[PubMed - indexed for MEDLINE]
5.

[Efficacy and safety of poly (gamma-glutamic acid) based nanoparticles (gamma-PGA NPs) as vaccine carrier].

Nakagawa S.

Yakugaku Zasshi. 2008 Nov;128(11):1559-65. Review. Japanese. Erratum in: Yakugaku Zasshi. 2008 Dec;128(12):1857.

PMID:
18981690
[PubMed - indexed for MEDLINE]
Free Article
6.

Vaccine adjuvant systems: enhancing the efficacy of sub-unit protein antigens.

Perrie Y, Mohammed AR, Kirby DJ, McNeil SE, Bramwell VW.

Int J Pharm. 2008 Dec 8;364(2):272-80. doi: 10.1016/j.ijpharm.2008.04.036. Epub 2008 Apr 30. Review.

PMID:
18555624
[PubMed - indexed for MEDLINE]
7.

Archaeosome immunostimulatory vaccine delivery system.

Patel GB, Chen W.

Curr Drug Deliv. 2005 Oct;2(4):407-21. Review.

PMID:
16305444
[PubMed - indexed for MEDLINE]
8.

Lipid-protamine-DNA-mediated antigen delivery.

Vangasseri DP, Han SJ, Huang L.

Curr Drug Deliv. 2005 Oct;2(4):401-6. Review.

PMID:
16305443
[PubMed - indexed for MEDLINE]
9.

Immunostimulatory colloidal delivery systems for cancer vaccines.

Saupe A, McBurney W, Rades T, Hook S.

Expert Opin Drug Deliv. 2006 May;3(3):345-54. Review.

PMID:
16640495
[PubMed - indexed for MEDLINE]
10.

Lipid-based self-adjuvanting vaccines.

Brown LE, Jackson DC.

Curr Drug Deliv. 2005 Oct;2(4):383-93. Review.

PMID:
16305441
[PubMed - indexed for MEDLINE]
11.

Cationic liposomes as vaccine adjuvants.

Christensen D, Korsholm KS, Rosenkrands I, Lindenstrøm T, Andersen P, Agger EM.

Expert Rev Vaccines. 2007 Oct;6(5):785-96. Review.

PMID:
17931158
[PubMed - indexed for MEDLINE]
12.

Liposomes and virosomes as delivery systems for antigens, nucleic acids and drugs.

Felnerova D, Viret JF, Glück R, Moser C.

Curr Opin Biotechnol. 2004 Dec;15(6):518-29. Review.

PMID:
15560978
[PubMed - indexed for MEDLINE]
13.

Archaeosome adjuvants: immunological capabilities and mechanism(s) of action.

Krishnan L, Sprott GD.

Vaccine. 2008 Apr 16;26(17):2043-55. doi: 10.1016/j.vaccine.2008.02.026. Epub 2008 Feb 27. Review.

PMID:
18343538
[PubMed - indexed for MEDLINE]
14.

Lipid based particulate formulations for the delivery of antigen.

Copland MJ, Rades T, Davies NM, Baird MA.

Immunol Cell Biol. 2005 Apr;83(2):97-105. Review.

PMID:
15748206
[PubMed - indexed for MEDLINE]
15.

Liposomes as antigen carriers and adjuvants in vivo.

Buiting AM, van Rooijen N, Claassen E.

Res Immunol. 1992 Jun;143(5):541-8; discussion 578-9. Review. No abstract available.

PMID:
1439135
[PubMed - indexed for MEDLINE]
16.

Enhancement of autologous tumor vaccine immunogenicity by anti-Gal.

LaTemple DC, Galili U.

Subcell Biochem. 1999;32:361-79. Review. No abstract available.

PMID:
10392003
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk